ImmuCell CorporationICCCNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR+19.6%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
+19.6%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202551.78%
202462.65%
2023-131.54%
2022-3085.51%
202192.34%
202021.14%
201944.19%
2018-1282.14%
2017-133.04%
2016-58.09%